Practice Management News

A study that used wastewater signals to identify cases of COVID-19 found that even a small increase in the proportion of people wearing masks at elementary schools in one California county significantly reduced the chance of a case.

SEATTLE — Recently published recommendations for the prevention of pediatric HIV infection say people with HIV should be counseled about infant feeding prior to conception or as early as possible in pregnancy.

Our third and final post in the series “Introduction to Taxation of Sales Proceeds” addresses the taxation of sale proceeds if a target practice is a partnership, including an LLC treated as a partnership.

Among primary care physicians, quarterly personalized antibiotic prescribing audits and feedback with peer benchmarking did not reduce antibiotic prescriptions, according to results of a randomized clinical trial in JAMA Internal Medicine.

In this video, Diane Havlir, MD, a University of California San Francisco professor, director of the AIDS Institute, and co-chair of the clinical section of the Conference on Retroviruses and Opportunistic Infections, provides insight into what she and other conference attendees can look forward to at this year’s meeting.

After 3 years as an all-virtual meeting, the Conference on Retroviruses and Opportunistic Infections returns this year to an in-person format at the new Summit Convention Center in Seattle.

Pandemic-related nonpharmaceutical interventions likely contributed to the decline in invasive bacterial disease incidence in the U.S. in 2020, not reductions in testing, according to a study in The Journal of Infectious Diseases.

A recent report found that about 18% of people with long COVID have been unable to return to work since their diagnosis, but primary care physicians can help patients manage the condition, an expert said.

The American Medical Association and 118 other medical societies, including the American College of Rheumatology, are urging CMS to finalize proposed rules aiming to reform prior authorization, according to a press release.

The FDA has rejected Phathom Pharmaceutical’s vonoprazan new drug application for erosive esophagitis, as well as its post-approval supplement for Helicobacter pylori, due to the presence of nitrosamine impurities.